ARCHIVES

Study: BRCA2-Negative Women Could Still Have High Risk

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

RFA Announced On Model For Planning community Prevention Program

October 20, 1978

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

ACCC Members Hear How Community Cancer Programs Are Developed

February 11, 1977

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Upton Tells Press He Wasn’t Hired To Push Prevention

August 5, 1977

Increased Breast Density Can Lead to Higher Risk

August 26, 2011